Insider Transactions in Q3 2022 at La Jolla Pharmaceutical CO (LJPC)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 22
2022
|
David A Ramsay Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
100,000
-100.0%
|
$600,000
$6.23 P/Share
|
|
Aug 22
2022
|
Tang Kevin C Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
19,215,868
-100.0%
|
$115,295,208
$6.23 P/Share
|
|
Aug 22
2022
|
Laura L. Johnson Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
500
-100.0%
|
$3,000
$6.23 P/Share
|
|
Aug 22
2022
|
Craig A Johnson Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
12,000
-100.0%
|
$72,000
$6.23 P/Share
|
|
Aug 22
2022
|
Michael S Hearne Chief Financial Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
9,607,934
-100.0%
|
$57,647,604
$6.23 P/Share
|
|
Aug 22
2022
|
Michael S Hearne Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
10,186
-100.0%
|
$61,116
$6.23 P/Share
|
|
Aug 22
2022
|
Larry G. Edwards Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
11,969
-100.0%
|
$71,814
$6.23 P/Share
|
|
Jul 08
2022
|
Craig A Johnson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+50.0%
|
$36,000
$3.93 P/Share
|